Antihistamine recall across the US triggered by heartburn drug contamination risk, FDA says

Antihistamine recall across the US triggered by heartburn drug contamination risk, FDA says

A generic model of the brand-name allergy treatment Zyrtec is below recall across the US attributable to potential cross-contamination with a heartburn drug, based on the Food and Drug Administration. Drugmaker Unique Pharmaceutical Laboratories is voluntarily recalling antihistamine medicine, generally used to deal with seasonal allergic reactions, over potential cross-contamination with ranitidine, a heartburn drug….

Read Full News